We would like to thank our partners this year, who support us with know-how and innovative formats.
AMEOS secures healthcare in the regions: At over 50 locations in our hospitals, polyclinics, rehabilitation, nursing and integration facilities, we are pioneers in medicine and care. AMEOS stands for comprehensive and future-proof care for the broad population in regional networks. Because for AMEOS, the most important thing is health.
Techniker Krankenkasse is the largest health insurance fund in Germany with over 11 million insured. The Mecklenburg-Vorpommern regional office is committed to demand-oriented improvements in the health care landscape. It also promotes numerous projects and supports the spirit of innovation in the state. Quality and efficiency - coupled with progressive care services for its insured - are the maxims.
Networked health. AOK Nordost is a reliable partner for people in Berlin, Brandenburg and Mecklenburg-Western Pomerania. As a leading regional health insurer, we focus on customer proximity and digital transformation. Together with our partners in the health care sector, we create customized care solutions for our policyholders in a strong network.
The Deutsche Kreditbank AG (DKB) headquartered in Berlin, was founded in 1990. Today, with almost 5,000 employees and total assets of EUR 121 billion, we are one of the top 20 banks in Germany. Our offers are leading in the market and are characterised by fair conditions. More than 570 nursing homes and hospitals use our financing solutions. DKB experts provide personal support to business customers at their location.
IIB e.V. is a university-aside research institution with the status of an affiliated institute of the University of Rostock. Based on the existing research infrastructure, the range of methods and the research achievements, the institute was appointed as a „Competence Center for Medical Technology MV“. The IIB e.V. is an independent institute in the field of biomedical engineering and is leading in the development of implants and their testing.
Klinikum Karlsburg near the Hanseatic and university city of Greifswald has an excellent reputation as a specialist clinic for heart and diabetes patients. The facility offers innovative cutting-edge medicine in the diagnosis and therapy of all cardiovascular diseases, especially diseases of the coronary vessels, the heart muscle, the heart valves and cardiac arrhythmias. As a supraregional centre, Karlsburg covers the entire spectrum of diabetology, including diabetes-associated complications. The German Diabetes Society has certified the clinic as a treatment facility for type 1 and type 2 diabetes as well as diabetes in children and adolescents and as an outpatient and inpatient foot treatment facility.
University Medicine Greifswald
University Medicine Greifswald (UMG) consists of 21 clinics, 19 institutes and other central facilities. The focus of the broad range of services is on molecular medicine and community medicine. The study places in human medicine, dentistry and nursing science are sought after nationwide. Measured against the rather small size, the research results and the third-party funds used are clearly above average: in the past year 2022, this amounted to over 35 million euros. The UMG has its origins in the founding of the university in 1456, which also brought the Faculty of Medicine into being.
University Medicine Rostock - cutting-edge medicine with a heart As the largest medical institution in the state of Mecklenburg-Vorpommern and rich in tradition, the University Medical Centre Rostock is the maximum care provider for the region. One of the largest employers in the north-east offers cutting-edge medicine from head to toe, which can hold its own in international comparison and ensures people's well-being every day of the year with modern technology and the latest treatment methods. The result is a triad of patient care, research and teaching.
The vfa is the association of research-based pharmaceutical companies in Germany. It represents the interests of 47 of the world's leading research-based pharmaceutical companies and more than 100 subsidiaries and affiliates in healthcare, research and economic policy. The members of the vfa represent more than two thirds of the entire German pharmaceutical market and employ about 80,000 people in Germany.